Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation.

Sekerkova A, Krepsova E, Brabcova E, Slatinska J, Viklicky O, Lanska V, Striz I.

BMC Immunol. 2014 Feb 6;15:4. doi: 10.1186/1471-2172-15-4.

2.

Monocyte implication in renal allograft dysfunction.

Guillén-Gómez E, Guirado L, Belmonte X, Maderuelo A, Santín S, Juarez C, Ars E, Facundo C, Ballarín JA, Vidal S, Díaz-Encarnación MM.

Clin Exp Immunol. 2014 Feb;175(2):323-31. doi: 10.1111/cei.12228.

3.

Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?

Castley A, Berry C, French M, Fernandez S, Krueger R, Nolan D.

PLoS One. 2014 Dec 29;9(12):e115226. doi: 10.1371/journal.pone.0115226. eCollection 2014.

4.

Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.

Tippett E, Cheng WJ, Westhorpe C, Cameron PU, Brew BJ, Lewin SR, Jaworowski A, Crowe SM.

PLoS One. 2011;6(5):e19968. doi: 10.1371/journal.pone.0019968. Epub 2011 May 20.

5.

Immunosuppression and monocyte subsets.

Rogacev KS, Zawada AM, Hundsdorfer J, Achenbach M, Held G, Fliser D, Heine GH.

Nephrol Dial Transplant. 2015 Jan;30(1):143-53. doi: 10.1093/ndt/gfu315. Epub 2014 Oct 13.

PMID:
25313167
6.

Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.

Lapuc I, Bolkun L, Eljaszewicz A, Rusak M, Luksza E, Singh P, Miklasz P, Piszcz J, Ptaszynska-Kopczynska K, Jasiewicz M, Kaminski K, Dabrowska M, Bodzenta-Lukaszyk A, Kloczko J, Moniuszko M.

Oncol Rep. 2015 Sep;34(3):1269-78. doi: 10.3892/or.2015.4088. Epub 2015 Jun 26.

PMID:
26135617
7.

Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients.

Moniuszko M, Bodzenta-Lukaszyk A, Kowal K, Lenczewska D, Dabrowska M.

Clin Immunol. 2009 Mar;130(3):338-46. doi: 10.1016/j.clim.2008.09.011. Epub 2008 Oct 25.

PMID:
18952503
8.
9.

A shift towards pro-inflammatory CD16+ monocyte subsets with preserved cytokine production potential after kidney transplantation.

Vereyken EJ, Kraaij MD, Baan CC, Rezaee F, Weimar W, Wood KJ, Leenen PJ, Rowshani AT.

PLoS One. 2013 Jul 29;8(7):e70152. doi: 10.1371/journal.pone.0070152. Print 2013.

10.

Impact of different immunosuppressive regimens on antigen-presenting blood cells in kidney transplant patients.

Scherberich JE, Estner H, Segerer W.

Kidney Blood Press Res. 2004;27(3):177-80. Epub 2004 Jul 13.

11.

CD16⁺ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunction.

Boersema M, van den Born JC, van Ark J, Harms G, Seelen MA, van Dijk MC, van Goor H, Navis GJ, Popa ER, Hillebrands JL.

Immunobiology. 2015 May;220(5):673-83. doi: 10.1016/j.imbio.2014.11.011. Epub 2014 Nov 21.

PMID:
25476849
12.

The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.

Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U.

Arthritis Rheum. 2012 Mar;64(3):671-7. doi: 10.1002/art.33418.

13.

Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.

Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K.

Clin Exp Immunol. 2005 Aug;141(2):270-8.

14.

Expansion and differentiation of CD14+CD16(-) and CD14+ +CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors.

Stec M, Weglarczyk K, Baran J, Zuba E, Mytar B, Pryjma J, Zembala M.

J Leukoc Biol. 2007 Sep;82(3):594-602. Epub 2007 Jun 26.

PMID:
17595380
15.

Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.

Simpson RJ, McFarlin BK, McSporran C, Spielmann G, ó Hartaigh B, Guy K.

Brain Behav Immun. 2009 Feb;23(2):232-9. doi: 10.1016/j.bbi.2008.09.013. Epub 2008 Oct 4.

PMID:
18930806
16.

Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment.

Venturini J, Cavalcante RS, Golim Mde A, Marchetti CM, Azevedo PZ, Amorim BC, Arruda MS, Mendes RP.

BMC Infect Dis. 2014 Oct 16;14:552. doi: 10.1186/s12879-014-0552-x.

17.

Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes.

Ferrer DG, Jaldín-Fincati JR, Amigone JL, Capra RH, Collino CJ, Albertini RA, Chiabrando GA.

Cytometry A. 2014 Jul;85(7):601-10. doi: 10.1002/cyto.a.22455. Epub 2014 Mar 17.

18.

Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.

Takeda S, Sato T, Katsuno T, Nakagawa T, Noguchi Y, Yokosuka O, Saito Y.

Dig Dis Sci. 2010 Jul;55(7):1886-95. doi: 10.1007/s10620-009-0974-2. Epub 2009 Nov 12.

PMID:
19908144
19.

CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.

Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Große-Dunker G, Heisel I, Hornof F, Jeken J, Rebling NM, Ulrich C, Scheller B, Böhm M, Fliser D, Heine GH.

J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20. doi: 10.1016/j.jacc.2012.07.019. Epub 2012 Sep 19.

20.

IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.

Ruppert J, Friedrichs D, Xu H, Peters JH.

Immunobiology. 1991 Aug;182(5):449-64.

PMID:
1717365
Items per page

Supplemental Content

Write to the Help Desk